Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > legacy shareholder whining

<< Previous

Bullboard Posts

Next >>

Post by Fuzzyboneon Jan 27, 2021 12:20pm

312 Views

Post# 32399592

legacy shareholder whining

Fact: the cheetos eating analysts were 200% correct
Fact: you know it all smarter than everybody else, we are the only ones who have a clue shareholders were wrong!!
when this stock when to $14 and you never took any profit, that says a lot about your investing skills
why don't you do all the silent investors on this board a favor and sell or shut UP!!! cause your sniffling and whining is fatiguing. your driving people away.

<< Previous

Bullboard Posts

Next >>

Full Circle Lithium goes global with its battery fire-fighter